Putnam Small Cap Growth R holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.
Putnam Small Cap Growth Fund Class R PSGRX
- NAV / 1-Day Return $79.09 / +2.55 %
- Fund Size $2.7B
- Adjusted Expense Ratio 1.420%
- Net Expense Ratio 1.360%
- Fee Level: Distribution Average
- Share Class Type Retirement, Medium
- Morningstar Category Small Growth
- Equity Style Box (Funds) Small Growth
- Minimum Initial Investment $0
- Investment Status Open
- TTM Yield 0.00%
- Turnover Ratio 83%
Morningstar’s Analysis PSGRX
Will PSGRX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 20.6
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
DigitalOcean Holdings Inc | 2.54 | 72M | Technology |
Halozyme Therapeutics Inc | 2.44 | 70M | Healthcare |
Huron Consulting Group Inc | 2.25 | 64M | Industrials |
RBC Bearings Inc | 2.19 | 62M | Industrials |
BrightSpring Health Services Inc | 2.02 | 57M | Healthcare |
Semtech Corp | 1.97 | 56M | Technology |
Applied Industrial Technologies Inc | 1.95 | 56M | Industrials |
Medpace Holdings Inc | 1.76 | 50M | Healthcare |
Onto Innovation Inc | 1.73 | 49M | Technology |
Covista Inc | 1.71 | 49M | Consumer Defensive |